Overview
Tomoyuki Fujiyama practices practicing medicine in Tsukuba, Japan.
Mr. Fujiyama is highly rated in 1 condition, according to our data. His clinical expertise encompasses Char Syndrome, Cerebral Hypoxia, and Drowsiness.
He is actively involved in clinical research, co-authoring 22 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Tomoyuki Fujiyama
Is Tomoyuki Fujiyama a top-rated expert for Char Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Tomoyuki Fujiyama is classified as an Advanced expert for Char Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Tomoyuki Fujiyama participate in research or clinical trials?
Yes. Tomoyuki Fujiyama has published 22 articles and abstracts on conditions like Char Syndrome. You can view a list of Tomoyuki Fujiyama's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Char SyndromeMr. Fujiyama isAdvanced. Learn about Char Syndrome.
- Experienced
- Cerebral HypoxiaMr. Fujiyama isExperienced. Learn about Cerebral Hypoxia.
- DrowsinessMr. Fujiyama isExperienced. Learn about Drowsiness.